Danimer Scientific(DNMR)
Search documents
Danimer Scientific(DNMR) - 2021 Q2 - Earnings Call Transcript
2021-08-17 00:28
Danimer Scientific, Inc. (NYSE:DNMR) Q2 2021 Earnings Conference Call August 16, 2021 5:00 PM ET Company Participants Russ Zukowski - Vice President of Corporate Finance Steve Croskrey - Chief Executive Officer Jad Dowdy - Chief Financial Officer Phillip Van Trump - Chief Science and Technology Officer Conference Call Participants Laurence Alexander - Jefferies Jon Tanwanteng - CJS Securities Operator Greetings. Welcome to the Danimer Scientific Second Quarter 2021 Earnings Call. At this time, all participa ...
Danimer Scientific(DNMR) - 2021 Q2 - Quarterly Report
2021-08-15 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common stock, $0.0001 par value per share DNMR New York Stock Exchange FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Co ...
Danimer Scientific(DNMR) - 2021 Q1 - Earnings Call Transcript
2021-05-18 03:48
Call Start: 17:00 January 1, 0000 5:49 PM ET Danimer Scientific, Inc. (NYSE:DNMR) Q1 2021 Earnings Conference Call May 17, 2021 17:00 ET Company Participants Russ Zukowski - Vice President of Corporate Finance Steve Croskrey - Chief Executive Officer John Dowdy - Chief Financial Officer Conference Call Participants Jon Tanwanteng - CJS Securities Laurence Alexander - Jefferies Operator Hello, and welcome to the Danimer Scientific's First Quarter 2021 Conference Call. Currently, all participants are in a lis ...
Danimer Scientific(DNMR) - 2021 Q1 - Quarterly Report
2021-05-17 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from Commission File Number: 001-39280 DANIMER SCIENTIFIC, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 84-1924518 ( State or other jurisdict ...
Danimer Scientific(DNMR) - 2020 Q4 - Earnings Call Transcript
2021-03-30 02:16
Danimer Scientific, Inc. (NYSE:DNMR) Q4 2020 Earnings Conference Call March 29, 2021 5:00 PM ET Company Participants Russ Zukowski - Vice President of Corporate Finance Steve Croskrey - CEO John Dowdy - CFO Conference Call Participants Jon Tanwanteng - CJS Securities Laurence Alexander - Jefferies Vincent Andrews - Morgan Stanley Operator Hello, and welcome to the Danimer Scientific Fourth Quarter and Full Year 2020 Conference Call. Currently, all participants are in listen-only mode. A question-and-answer ...
Danimer Scientific(DNMR) - 2020 Q4 - Annual Report
2021-03-29 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common stock, $0.0001 par value per share DNMR New York Stock Exchange Warrants to purchase one share of Common Stock DNMR WS New York Stock Exchange FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE S ...
Danimer Scientific(DNMR) - 2020 Q3 - Quarterly Report
2020-11-05 21:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39280 Live Oak Acquisition Corp. (Exact name of registrant as specified in its charter) | --- | |--------------------------------- ...
Danimer Scientific(DNMR) - 2020 Q2 - Quarterly Report
2020-07-31 12:44
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39280 Live Oak Acquisition Corp. (Exact name of registrant as specified in its charter) | --- | --- | |-------------------------------- ...